CEL-SCI to Present New Data for Multikine ® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress

Tomas Kauer - Moderator

Sep 10, 2024 - 22:00

CEL-SCI to Present New Data for Multikine ® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress

Tags:

Previous Article

Thunderbird Distribution acquires global media and consumer products rights to n...

Baird lifts Axon stock target, keeps outperform rating on growth potential

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

Foster sisters explain why they haven’t invested in AI

Foster sisters explain why they haven’t invested in AI

Tomas Kauer - Mode... Oct 29, 2024

Acrew Capital hits five years, raises $700M

Acrew Capital hits five years, raises $700M

Tomas Kauer - Mode... Oct 19, 2024

China's lending to Africa rises for first time in seven years, study shows

China's lending to Africa rises for first time in seven...

Tomas Kauer - Mode... Sep 1, 2024